Recent research shows that some non-steroidal anti-inflammatory drugs increase cardiovascular risk in some patients. Given their widespread use, and breadth of indications for prescription, should clinicians be more circumspect about their practice?
In this podcast, Mabel Chew BMJ’s practice editor, talks to Richard O’Day, professor of clinical pharmacology at the University of New South Wales and author of a recent therapeutics article, about the latest research on NSAIDs